World Journal of Clinical Cases

Papers
(The H4-Index of World Journal of Clinical Cases is 26. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2020-11-01 to 2024-11-01.)
ArticleCitations
Omicron variant (B.1.1.529) of SARS-CoV-2: Mutation, infectivity, transmission, and vaccine resistance262
Cardiovascular impact of COVID-19 with a focus on children: A systematic review79
Fear of missing out: A brief overview of origin, theoretical underpinnings and relationship with mental health79
Spirituality, religiousness, and mental health: A review of the current scientific evidence76
Major depressive disorder: Validated treatments and future challenges58
Herb-induced liver injury: Systematic review and meta-analysis46
COVID-19: An overview and a clinical update41
Cardiac rehabilitation and its essential role in the secondary prevention of cardiovascular diseases38
Remimazolam benzenesulfonate anesthesia effectiveness in cardiac surgery patients under general anesthesia38
Diabetes mellitus and COVID-19: Understanding the association in light of current evidence36
Risk factors and digital interventions for anxiety disorders in college students: Stakeholder perspectives35
Expert consensus on the diagnosis and treatment of myofascial pain syndrome34
Beta-carotene and its protective effect on gastric cancer33
Gut microbiota and inflammatory bowel disease: The current status and perspectives33
COVID-19 and the digestive system: A comprehensive review32
Chronic hepatitis-C infection in COVID-19 patients is associated with in-hospital mortality31
eHealth, telehealth, and telemedicine in the management of the COVID-19 pandemic and beyond: Lessons learned and future perspectives31
Gut-brain axis: Focus on gut metabolites short-chain fatty acids30
COVID-19: Gastrointestinal manifestations, liver injury and recommendations30
Superior mesenteric artery syndrome: Diagnosis and management29
Strategies and challenges in the treatment of chronic venous leg ulcers29
Current guidelines for Helicobacter pylori treatment in East Asia 2022: Differences among China, Japan, and South Korea28
Role of visfatin in obesity-induced insulin resistance28
No significant association between dipeptidyl peptidase-4 inhibitors and adverse outcomes of COVID-1927
COVID-19 infection and liver injury: Clinical features, biomarkers, potential mechanisms, treatment, and management challenges27
Mesenchymal stem cell-derived exosomes: An emerging therapeutic strategy for normal and chronic wound healing27
Role of metabolites derived from gut microbiota in inflammatory bowel disease26
0.59368491172791